XOMA News and Press, XOMA Corporation From 07/30/19

EMERYVILLE, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the 2019 Wedbush PacGrow Healthcare Conference in New York, New York.  The presenta...

EMERYVILLE, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) announced today that gevokizumab, an anti-IL1β monoclonal antibody that XOMA discovered and initially developed, is now actively progressing in a Novartis oncology development program.  The ant...

Shares of XOMA Corporation (XOMA) have lost over 90% of their value during the past 10 years and are in the red by roughly 30% in the past 12 months. In 2018, it was noted that, since formation (in 1981), the company burned through an astounding $1.2 billion of capital and failed to bring a dr...

XOMA (NASDAQ: XOMA ): Q1 GAAP EPS of $0.21 beats by $0.08 . More news on: XOMA Corporation, Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

Acquired rights to potential milestone and royalty payments associated with five hematology assets Received $5.5 million milestone payment Added Barbara Kosacz to XOMA’s Board of Directors Current cash balance sufficient to fund operations for multiple years EMERYVILLE, Cal...

XOMA Corporation (NASDAQ: XOMA ) has agreed to acquire the rights to royalty payments and a portion of milestone payments associated with five hematology assets from Aronora, Inc., out of which three of the assets are anti-thrombotic candidates covered by a collaboration with Bayer. ...

EMERYVILLE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today it has agreed to acquire the rights to potential royalty payments and a portion of the potential milestone payments associated with five hematology assets from Aronora, Inc.  Three of...

EMERYVILLE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the 2019 H.C. Wainwright Global Life Sciences in London, United Kingdom.  The pres...

The following slide deck was published by XOMA Corporation in conjunction with this Read more ...

XOMA (NASDAQ: XOMA ): Q4 GAAP EPS of -$0.35. More news on: XOMA Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...